A history of human-like dieting alters serotonergic control of feeding and neurochemical balance in a rat model of binge-eating

Int J Eat Disord. 2007 Mar;40(2):136-42. doi: 10.1002/eat.20349.

Abstract

Objective: This study replicated a model of stress-induced binge-eating in rats with a history of caloric restriction (HCR), tested their response to SSRI (fluoxetine) treatment, and explored changes in brain monoamine levels.

Method: Young female rats with no-HCR/no-Stress, no-HCR/Stress, HCR/no-Stress, and HCR+Stress (binge-eating) were treated with fluoxetine. Post-mortem levels of serotonin, dopamine, and metabolites were assessed from brain regions key to feeding and reward.

Results: A 3 mg/kg dose of fluoxetine without effect in the no-HCR groups suppressed intake of HCR groups, normalizing the binge-eating of HCR/Stress rats. No differences in monoamines were detected in the hypothalamus or tegmentum but a strong positive relationship between accumbens serotonin and dopamine turnover in no-HCR rats was absent in rats with HCR.

Conclusion: Despite lack of hunger, a history of human-like dieting alters serotonin function in ways suggesting consequences not only to feeding but also control of reward and mood that are dependent on dopamine/serotonin interactions.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3,4-Dihydroxyphenylacetic Acid / metabolism
  • Animals
  • Antidepressive Agents, Second-Generation / pharmacology
  • Brain / pathology*
  • Bulimia / pathology*
  • Diet, Reducing / adverse effects*
  • Disease Models, Animal*
  • Dopamine / metabolism*
  • Energy Intake / physiology
  • Feeding Behavior / physiology*
  • Female
  • Fluoxetine / pharmacology
  • Humans
  • Hydroxyindoleacetic Acid / metabolism
  • Hypothalamus / pathology
  • Injections, Intraperitoneal
  • Norepinephrine / metabolism
  • Nucleus Accumbens / pathology
  • Rats
  • Rats, Sprague-Dawley
  • Serotonin / metabolism*
  • Tegmentum Mesencephali / pathology

Substances

  • Antidepressive Agents, Second-Generation
  • Fluoxetine
  • 3,4-Dihydroxyphenylacetic Acid
  • Serotonin
  • Hydroxyindoleacetic Acid
  • Dopamine
  • Norepinephrine